手術における制御試験

Same author

Patient Engagement in the Implementation of Electronic Patient-Reported Outcome Tools: The Experience of Two Early-Adopter Institutions in the Pan-Canadian Radiotherapy Patient-Reported Outcome Initiative.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025

Same author

Succinate dehydrogenase mutations: paraganglioma imaging and at-risk population screening.

Clinical radiology·2018

Same author

Proposal for Prevention or Alleviation of Protein/Lymph-Losing Enteropathy (PLE/LLE) After Fontan Circulation Treatment of Univentricular Hearts: Restoration of Lymph Balance With a "Lymphatic Right-to-Left Shunt."

Lymphology·2018

Same author

Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regionally Metastatic Melanoma: A Retrospective Database Analysis.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016

Same author

Cost-Effectiveness Analysis of Panitumumab Plus Mfolfox6 Versus Bevacizumab Plus Mfolfox6 for First-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016

Same author

Unmet clinical needs in the management of advanced melanoma: findings from a survey of oncologists.

European journal of cancer care·2015

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

手術における制御試験

関連する概念動画

Patient Engagement in the Implementation of Electronic Patient-Reported Outcome Tools: The Experience of Two Early-Adopter Institutions in the Pan-Canadian Radiotherapy Patient-Reported Outcome Initiative.

Succinate dehydrogenase mutations: paraganglioma imaging and at-risk population screening.

Proposal for Prevention or Alleviation of Protein/Lymph-Losing Enteropathy (PLE/LLE) After Fontan Circulation Treatment of Univentricular Hearts: Restoration of Lymph Balance With a "Lymphatic Right-to-Left Shunt."

Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regionally Metastatic Melanoma: A Retrospective Database Analysis.

Cost-Effectiveness Analysis of Panitumumab Plus Mfolfox6 Versus Bevacizumab Plus Mfolfox6 for First-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer.

Unmet clinical needs in the management of advanced melanoma: findings from a survey of oncologists.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

手術における制御試験

関連する概念動画

関連記事

Patient Engagement in the Implementation of Electronic Patient-Reported Outcome Tools: The Experience of Two Early-Adopter Institutions in the Pan-Canadian Radiotherapy Patient-Reported Outcome Initiative.

Succinate dehydrogenase mutations: paraganglioma imaging and at-risk population screening.

Proposal for Prevention or Alleviation of Protein/Lymph-Losing Enteropathy (PLE/LLE) After Fontan Circulation Treatment of Univentricular Hearts: Restoration of Lymph Balance With a "Lymphatic Right-to-Left Shunt."

Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regionally Metastatic Melanoma: A Retrospective Database Analysis.

Cost-Effectiveness Analysis of Panitumumab Plus Mfolfox6 Versus Bevacizumab Plus Mfolfox6 for First-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer.

Unmet clinical needs in the management of advanced melanoma: findings from a survey of oncologists.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.